News
Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the 13 Best Healthcare Stocks to Buy Under $10. On May 1, analyst Ritu ...
1don MSN
Andrew Charles, TD Cowen analyst, joins CNBC's 'Squawk on the Street' to discuss what potential tariffs on Brazil could mean ...
2don MSN
Craig Hutchinson, TD Cowen base metals equity research analyst, joins 'Squawk Box' to discuss which stocks can benefit from ...
TD Cowen analyst Gregory Williams maintained a Hold rating on AT&T on July 7 and set a price target of $30.00. The company’s shares closed today at $26.97. Take advantage of TipRanks Premium at 50% ...
Alphabet Inc. (NASDAQ:GOOGL) is one of the AI Stocks Making Waves on Wall Street. On July 9, TD Cowen analyst John Blackledge ...
The chip maker sells the basic building-block chips that go into products in nearly every sector of the economy, from autos ...
Explore more
Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk could generate more than $30 billion in sales by 2035, analysts at TD ...
Pricing expectations stalled in second-quarter 2025 and remain below our rail shipper survey’s long-term average. Business ...
The analysts expect TI’s flexible capital expenditure plans beyond 2025 to support a sharp improvement in free cash flow.
Enphase Energy falls following President Trump's executive order to scrap clean electricity tax credits faster than expected ...
The investment banking arm of TD Bank believes that the market cap of JPMorgan will soar to $1 trillion as it leverages ...
In a report released today, William Katz from TD Cowen maintained a Hold rating on Invesco, with a price target of $17.50. The company’s shares closed yesterday at $17.40. Eleva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results